Journals / Türk Kardiyoloji Derneği Arşivi / 2017 / Cilt: 45 - Sayı: Suppl. 5

Vaccination in the elderly population

Yaşlı popülasyonda bağışıklama (aşılama)

Pages
124–127
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is recommended that all adults over 65 years old, and for adults younger than 65 years who have certain chronic health conditions receive seasonal influenza vaccination annually, pneumococcal vaccines and zoster vaccine.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:It is known that the immune systems tend to weaken over time, putting elderly patients at higher risk for chronic diseases such as cardiovascular (CV) diseases, diabetes, chronic renal disorders and their complication as well as infectious disease leading to an increased mortality and morbidity rates in patients over 65 years old.
📊
Key Findings & Data:Vaccination, a prophylactic treatment strategy, means that immunogenic materials from pathogens (or tumours) are administered to generate an adequate immune response specifically to these antigens.
💡
Conclusion & Impact:It is recommended that all adults over 65 years old, and for adults younger than 65 years who have certain chronic health conditions receive seasonal influenza vaccination annually, pneumococcal vaccines and zoster vaccine.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

It is known that the immune systems tend to weaken over time, putting elderly patients at higher risk for chronic diseases such as cardiovascular (CV) diseases, diabetes, chronic renal disorders and their complication as well as infectious disease leading to an increased mortality and morbidity rates in patients over 65 years old. Vaccination, a prophylactic treatment strategy, means that immunogenic materials from pathogens (or tumours) are administered to generate an adequate immune response specifically to these antigens. Vaccine-preventable diseases which can affect the elderly population are influenza, pneumococcal disease, tetanus, hepatitis B and zona zoster. It is recommended that all adults over 65 years old, and for adults younger than 65 years who have certain chronic health conditions receive seasonal influenza vaccination annually, pneumococcal vaccines and zoster vaccine. Also tetanus vaccine administration is recommended every 10 years in adults.

Özet

Yaşlanma ile birlikte bağışıklık sisteminin zayıfladığı, kalp damar hastalığı, kronik böbrek yetersizliği, diyabet gibi kronik hastalıklar ve bu hastalıklara bağlı komplikasyonlar sonucu mortalite ve morbiditenin arttığı bilinmektedir. Aşılama bir başka deyişle bağışıklama, patojenlerden ya da tümörden elde edilen immünolojik materyalin verilmesiyle kişide yeterli bir immünolojik cevap oluşturmak ve bireyde bağışıklık düzeyini istenilen seviyeye getirmek amacıyla yapılan koruyucu bir işlemdir. Yaşlıları etkileyebilecek ve bağışıklama ile önlenebilecek hastalıkların başında influenza (grip), pnömokokal hastalıklar (pnömoni, menenjit,sepsis), tetanoz, Hepatit B ve zona zoster hastalığı sayılabilir. Altmış beş yaş üstü tüm bireylerin her yıl bir kez mevsimsel grip aşısı yanısıra pnömokok ve zona aşı- sı yaptırmaları ayrıca 10 yılda bir tetanoz aşısı rapeli olmaları önerilmektedir.

🔖

Cite This Article

KOLDAŞ, Z. L. (2022). Vaccination in the elderly population. Türk Kardiyoloji Derneği Arşivi, Cilt: 45 - Sayı: Suppl. 5, 124–127. https://ajindex.com/articles/632328

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. He W, Goodkind D, Kowal P. An Aging World: 2015 Census Bureau. Availableat:https://www.census.gov/content/dam/Census/library/publications/2016/demo/p95-16-1.pdf. Accessed Aug 10, 2017
  2. İstatistiklerle Yaşlılar 2016. TÜİK Haber Bülteni 2017:24644. Avilable at:www.tuik.gov.tr/PdfGetir.do?id=24644. Accessed Mar 16, 2017
  3. Centers for Disease Control and Prevention. In: Atkinson W, Hamborsky J,Stanton A, Wolfe C, editors. Epidemiology and Prevention of Vaccine-Preventable Diseases—The Pink Book. Pneumococcal Disease. 10th ed. Public Health Foundation; 2007. p. 255–68
  4. Özcan M. Türk Geriatri Kongresi Özel Sayısı 2012;15:42–3. Available at: http://www.turkgeriatrivakfi.org.tr/uploads/tgv/merkez/html/saglikli_yasam/ asi_bagisiklama.htm. Accessed Aug 10, 2017
  5. Derhovanessian E, Pawelec G. Vaccination in the elderly. Microb Biotechnol 2012;5:226–32
  6. Nichol KL. Improving influenza vaccination rates among adults. Cleve Clin J Med 2006;73:1009–15
  7. McElhaney JE. Influenza vaccine responses in older adults. Ageing Res Rev 2011;10:379–88
  8. Türkiye Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Uzmanlık Derneği (EKMUD) Erişkin Bağışıklama Rehberi; Yaşlılık döneminde aşılama. İstanbul: Gülmat Matbaacılık: 2016
  9. Lang PO, Govind S, Mitchell WA, Siegrist CA, Aspinall R. Vaccine effectiveness in older individuals: what has been learned from the influenza-vaccine experience. Ageing Res Rev 2011;10:389–95
  10. Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007;82:1341–9
  11. Türkiye Halk Sağlığı Kurumu, Yetişkin Risk Grubu Aşılama Programı, http://www.adanahsm.gov.tr/uploads/files/Risk%20Grubu%20 A%C5%9F%C4%B1lamalar%C4%B1.pdf (Son Erişim Tarihi: 15 Ağustos 2017)